October 7, 2022
Ono Pharmaceutical’s PD-1 inhibitor Opdivo (nivolumab) brought in the largest sales in the Japan pharma market in September, holding the top spot for the ninth straight month, according to a monthly snapshot report released by Encise. Opdivo racked up sales...read more